DI-086 Review of off-label use and economic impact of intravitreal dexamethasone implants in a tertiary hospital

MAR Gómez, AI Zurriaga, ER Herráiz… - European Journal of …, 2014 - ejhp.bmj.com
Background Intravitreal dexamethasone implants (DEXi) were approved by the European
Medicines Agency in 2010 to treat macular oedema following either branch or central retinal …

CP-148 Impact on drug adherence and viral load after pharmaceutical intervention in selected hepatitis B outpatients

MAR Gómez, CM Nieto, ER Herraiz, ED Gómez… - 2016 - ejhp.bmj.com
Background The outpatient pharmacy unit (OPU), in consensus with the digestive service
(DIG), held an intervention on selected chronic hepatitis B virus (HBV) infected outpatients. It …